Geist William 4

Accession 0001062993-25-014697

CIK 0000842023other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 5:27 PM ET

Size

25.5 KB

Accession

0001062993-25-014697

Form 4

Period: 2025-08-15

PRESIDENT, PROTEIN SCIENCES

Transactions

Exercise/Conversion
Common Stock
2025-08-15+2,623→ 15,915 total
Award
Restricted Stock Units
2025-08-15+9,678→ 9,678 total
→ Common Stock (9,678 underlying)
Exercise/Conversion
Restricted Stock Units
2025-08-15−2,623→ 5,246 total
→ Common Stock (2,623 underlying)
Award
Stock Options (Right to Buy)
2025-08-15+24,758→ 24,758 total
Exercise: $53.60Exp: 2035-08-15→ Common Stock (24,758 underlying)
Tax Payment
Common Stock
2025-08-15$53.60/sh−803$43,041→ 15,112 total
Award
Performance Restricted Stock Units
2025-08-15+19,355→ 19,355 total
→ Common Stock (19,355 underlying)

Holdings

Performance Stock Options (Right to Buy)
Exercise: $84.61→ Common Stock (24,424 underlying)
24,424
Restricted Stock Units
→ Common Stock (9,911 underlying)
9,911
Performance Restricted Stock Units
→ Common Stock (15,738 underlying)
15,738
Stock Options (Right to Buy)
Exercise: $100.39Exp: 2029-02-01→ Common Stock (15,912 underlying)
15,912
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (29,600 underlying)
29,600
Performance Restricted Stock Units
→ Common Stock (9,074 underlying)
9,074
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (30,059 underlying)
30,059
Stock Options (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (21,204 underlying)
21,204

Footnotes (12)

[F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F10]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F11]3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
[F12]Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.
[F2]Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026.
[F3]Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
[F4]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F5]Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
[F6]9,911 restricted stock units vest on 11/1/2025.
[F7]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F8]2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
[F9]Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother